Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus MOVIPREPÂ® Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults.